Nestle selling U.S. candy brands to Nutella company

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

SAN FRANCISCO, CA - FEBRUARY 18: Nestle Butterfinger and Baby Ruth candy bars are displayed on a shelf at a convenience store on February 18, 2015 in San Francisco, California. Nestle USA announced plans to remove all artificial flavors and FDA-certified colors from its entire line of chocolate candy products, including the popular Butterfinger and Baby Ruth candy bars, by the end of 2015. (Photo by Justin Sullivan/Getty Images)

Nestle is selling nearly $3 billion worth of its U.S. candy brands, including Butterfinger, BabyRuth and Nerds, to Ferrero, the maker of Nutella, according to the companies.

Nestle said Ferrero will acquire more than 20 of its U.S. confectionery brands, allowing the company to focus on non-candy products from its U.S. division like pet products, bottled water, coffee, frozen food and baby nutrition.

Nestle, a massive food and beverage company based in Switzerland, is well-known for its chocolate and candy like 100Grand, Raisinets, and Crunch.

Even though its candy sales reached about $900 million in the U.S. in 2016, confections make up a small part of Nestle’s U.S. sales, which totaled nearly $28 billion the same year, according to the company.

Nestle manages over 2,000 brands around the world including Gerber baby food, Purina Cat Chow and Nescafe.

The company said it remains committed to its international chocolate business, including its KitKat brand.

Hershey has the license for KitKat in the U.S. But Nestle still owns the brand and it’s not part of the Ferrero deal.

With the $2.8 billion deal, Italian candy maker Ferrero will become the third-largest confectionery company in the U.S., a press release said. Ferrero is known in the U.S. market for items like Tic Tac breath mints, Brach’s and its Nutella hazelnut spread,

The deal is expected to close after the first quarter if it clears regulatory approval.